Act5C regulatory sequences control expression of a QF2w driver (a derivative of QF in which the middle domain is completely deleted and the activation domain is mutated to reduce activity by altering the charge on the C-terminus).
Act5C regulatory sequences control expression of a QF2w driver (this is a weaker transactivator and shows slightly less toxicity compared to the QF2 driver).